M&A Deal Summary

Aragen Life Sciences Acquires Vanta Bioscience LC

On November 7, 2014, Aragen Life Sciences acquired life science company Vanta Bioscience LC

Acquisition Highlights
  • This is Aragen Life Sciences’ 2nd transaction in the Life Science sector.
  • This is Aragen Life Sciences’ 2nd transaction in the United States.
  • This is Aragen Life Sciences’ 1st transaction in Iowa.

M&A Deal Summary

Date 2014-11-07
Target Vanta Bioscience LC
Sector Life Science
Buyer(s) Aragen Life Sciences
Deal Type Add-on Acquisition

Target

Vanta Bioscience LC

Des Moines, Iowa, United States
Vanta Bioscience is a provider of pre-clinical contract research organization with research laboratories.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Aragen Life Sciences

Hyderabad, India

Category Company
Founded 2001
Sector Life Science
DESCRIPTION

Aragen Life Sciences is a provider of outsourced discovery, development, and manufacturing services across both large and small molecule platforms. Aragen Life Sciences was founded in 2001 and is based in Hyderabad, India.


DEAL STATS #
Overall 2 of 3
Sector (Life Science) 2 of 3
Type (Add-on Acquisition) 2 of 3
State (Iowa) 1 of 1
Country (United States) 2 of 2
Year (2014) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-02-28 Aragen Bioscience

Morgan Hill, California, United States

Aragen Bioscience, Inc. is a preclinical custom contract research organization that provides in vitro and in vivo research to pharmaceutical, biotechnology and research institutions.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-15 Intox

Pune, India

Intox is a reputed GLP certified pre-clinical contract research organization (CRO) with its test facilities. Intox was founded in 1995 and is based in Pune, India.

Buy -